ELIAS Animal Health Blog
Read the latest news and updates from ELIAS Animal Health
ELIAS Animal Health Cancer Immunotherapy selected for state of the art presentation at VCS Mid‐Year Conference
Olathe, Kan., Feb. 12, 2018 – ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in [...]
ELIAS Animal Health adds clinical trial site for ECI™ for the treatment of canine osteosarcoma
ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, is offering a fourth [...]
First patient enrolled in ELIAS clinical trial for treatment of canine b-cell lymphoma
Olathe, Kan., Aug. 24, 2016 – ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in [...]
ELIAS Animal Health names Ronald Schultz and Noe Reyes to Scientific Advisory Board
Olathe, Kan., September 1, 2015 - ELIAS Animal Health, a clinical stage development company advancing novel targeted T cell-based immunotherapy [...]
Clinical trial launch: ECI-OSA-11 for the treatment of canine osteosarcoma
Olathe, Kan., Aug. 4, 2015 - ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in [...]